Clinical trial
Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous…
NCT00317980 · University of Brasilia, Other · Completed
Key facts
| NCT number | NCT00317980 |
|---|---|
| Title | Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis |
| Official title | Phase IV Randomized Controlled Clinical Trial to Evaluate the Safety and Efficacy of Low-Dose Pentavalent Antimony Compared to the Standard Dose in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia)Braziliensis |
| Acronym | Lowdosesb |
| Lead sponsor | University of Brasilia, Other |
| Collaborators | Ministry of Health, Brazil |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cutaneous Leishmaniasis |
| Intervention type | Drug |
| Interventions | Meglumine antimoniate |
| Enrollment | 280 |
| Start date | Feb 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Apr 25, 2006 |
| Last update posted | Jan 22, 2009 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: